<DOC>
	<DOCNO>NCT01017757</DOCNO>
	<brief_summary>Immunosuppressive drug tacrolimus , cyclosporine , mycophenolate mofetil , sirolimus everolimus may toxic pulmonary effect , particularly interstitial alteration . The aim present study explore presence subclinical interstitial lung abnormality stable renal transplant recipient take different immunosuppressive drug use maintenance therapy renal transplantation .</brief_summary>
	<brief_title>Interstitial Lung Abnormalities Renal Transplant Recipients</brief_title>
	<detailed_description>Prospective , cross-sectional study examine high-resolution CT scan obtain 63 stable renal transplant recipient take immunosuppressive treatment least 24 month . The findings patient take new immunosuppressive drug ( mycophenolic acid , sirolimus everolimus ) compare patient treat traditional way ( cyclosporine , tacrolimus , azathioprine ) . All patient undergo high-resolution CT scanning . Eligibility criterion : recipient kidney kidney-pancreas transplant , immunosuppressive therapy least 24 month , stable renal function absence overt lung disease lung alteration induce drug , systemic disease occupational exposure fibrogenic agent .</detailed_description>
	<criteria>Renal transplant patient stable renal function take immunosuppressive therapy least 24 month provide write informed consent participate study Overt lung disorder , lung toxicity due drug occupational exposure lungtoxic agent Systemic connective tissue disorder systemic vasculitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>82 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Interstitial lung disease</keyword>
	<keyword>Immunosuppressive therapy</keyword>
	<keyword>Renal transplant</keyword>
</DOC>